We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Significance of Funguria in Hospitalized Patients (FACES)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00787085
First Posted: November 7, 2008
Last Update Posted: November 7, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
Cedars-Sinai Medical Center
Information provided by:
Los Angeles Biomedical Research Institute
November 6, 2008
November 7, 2008
November 7, 2008
September 2001
February 2006   (Final data collection date for primary outcome measure)
Funguria [ Time Frame: Hospitalization day 0, 3, 7, 14, and every 7 days thereafter until hospital discharge or death ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
The Significance of Funguria in Hospitalized Patients
The Significance of Funguria in Hospitalized Patients (FACES)
This investigation is a epidemiologic case-control study of the risk factors associated with nosocomial funguria (fungi in the urine).

A recent large multi-center national surveillance survey of almost 5000 nosocomial (hospital based) urine isolates from medical intensive care units demonstrated that fungi comprised nearly 40% of urine isolates. Little is known about distinguishing fungi that cause colonization from those causing infection.

The objective of this study is to define the epidemiology of nosocomial funguria and natural history of patients that develop funguria while hospitalized.

Patients who may have eligible for this study will be identified from microbiology laboratory specimens at the Harbor-UCLA Medical Center and Cedars-Sinai Medical Center.

Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
Urine and blood cultures
Non-Probability Sample
Patients hospitalized at the Harbor-UCLA Medical Center and Cedars-Sinai Medical Center
Urinary Tract Infections
Not Provided
  • Case
    Patients hospitalized with a urine or blood culture positive for fungi
  • Control
    Patients hospitalized with a urine culture negative for fungi
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
919
February 2006
February 2006   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients hospitalized at least 12 hours of any age (< 1 day to > 100 years of age) AND a urine or blood culture positive for fungi, OR urine culture negative for fungi (control group)

Exclusion Criteria:

  • Patients already surveyed for funguria during current hospitalization and patients already being followed for recognized funguria
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00787085
10024-05
NIH-AI01831
Yes
Not Provided
Not Provided
Loren Gregory Miller, M.D., M.P.H., Principal Investigator, Los Angeles Biomedical Research Institute
Los Angeles Biomedical Research Institute
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • Cedars-Sinai Medical Center
Principal Investigator: Loren G Miller, M.D., M.P.H. Los Angeles Biomedical Research Institute
Los Angeles Biomedical Research Institute
November 2008